
Join to View Full Profile
128 Peachtree DriveRockport, TX 78382
Phone+1 210-419-4226
Dr. Atiee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. George Atiee is a family medicine specialist based in Rockport, TX. He completed his residency in family medicine at Baylor College of Medicine from 1985 to 1988, after graduating in 1985 from The University of Texas Health Science Center at San Antonio. Dr. Atiee has authored multiple publications in scientific journals, including studies on pharmacokinetics, safety, and tolerability of various medications and treatments. His research contributions have been cited by other publications, reflecting engagement with the academic community. He has completed over 400 Phase 1 Clinical Trials in a multitude of therapeutic areas. Most recently, he has been appointed as the Director of Medical Monitoring Services for Dr. Vince Clinical Research.
Education & Training
- Baylor College of MedicineResidency, Family Medicine, 1985 - 1988
- The University of Texas Health Science Center at San AntonioClass of 1985
Certifications & Licensure
- NE State Medical License 2010 - 2026
- IN State Medical License 1998 - 2025
- KS State Medical License 2022 - 2025
- TX State Medical License 1986 - 2025
Clinical Trials
- Safety of ALK Ragweed Tablet Start of enrollment: 2006 May 01
- Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. Start of enrollment: 2007 Jan 01
- Safety, Reactogenicity and Immunogenicity of an H5N1 VLP Start of enrollment: 2007 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPopulation pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens.Jürgen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee
Antimicrobial Agents and Chemotherapy. 2024-04-03 - A phase I, first-in-human study to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of MRG-001 in healthy subjects.Ali R Ahmadi, George Atiee, Bart Chapman, Laurie Reynolds, John Sun
Cell Reports. Medicine. 2023-09-19 - A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis.Christine K Mauck, George J Atiee, Jennifer McCulloh, Laurie Reynolds, Nadene Zack
The Journal of Antimicrobial Chemotherapy. 2022-12-23
Press Mentions
- Effective Study Design and Execution of Renal and Hepatic Impairment Trials, Upcoming Webinar Hosted by XtalksOctober 21st, 2024
- Worldwide Clinical Trials Implements ClinSpark eSource PlatformOctober 17th, 2019
- Worldwide Clinical Trials Expert to Present at Outsourcing in Clinical Trials West CoastFebruary 13th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: